Table 5.
Antimicrobial Resistance Patterns of ESβL-Producing Gram-Negative Bacilli Among Hospitalized Neonates
| Bacteria | No. (%) of Resistant Isolates Respective to Each Antibiotics | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| AMC | AUG | GEN | AMK | TE | NAL | CIP | SXT | CRN | MER | |
| K. pneumoniae (n=23) | 23(100) | 23(100) | 23(100) | 0 (0) | 20(87) | 6(26.1) | 15(65.2) | 19(82.6) | 14(60.6) | 2(8.7%) |
| E. coli (n=17) | 17(100) | 16(94) | 11(64.7) | 2(11.8) | 11(64.7) | 2(11.8) | 7(41.2) | 7(41.2) | 8(47.1) | 2(11.8) |
| K. oxytoca (n=14) | 14(100) | 12(85.7) | 13(93) | 0 (0) | 13(93) | 3(21.4) | 8(57.1) | 8(57.1) | 10(71.4) | 2(14.3) |
| Enterobacter spps (n=6) | 6(100) | 4(100) | 4(66.7) | 1(16.7) | 4(66.7) | 3(50) | 2(33.3) | 5(83.3) | 2(33.3) | 0(0) |
| Citrobacter spps (n=4) | 4(100) | 4(100) | 1(25) | 1(25) | 1(25) | 1(25) | 2 (50) | 1(25) | 2 (50) | 1(25) |
| M. morganii (n=3) | 3(100) | 3(100) | 2(66.7) | 0 (0) | 1(33.3) | 1(33.3) | 2(66.7) | 2(66.7) | 1(33.3) | 1(33.3) |
| Proteus spps (n=3) | 3(100) | 3(100) | 1(33.3) | 0 (0) | 2(66.7) | 0 (0) | 0 (0) | 1(33.3) | 2(66.7) | 0(0) |
| P. aeruginosa (n=2) | 2(100) | 2(100) | 2(100) | 1(50) | 1(50) | 0 (0) | 1(50) | 2(100) | 2(100) | 0(0) |
| Total (n=72) | 72(100) | 69(95.8) | 57(79.2) | 5(6.9) | 53(73.6) | 16(22) | 37(51.4) | 45(62.5) | 41(56.9) | 8(11) |
Abbreviations: AMC, ampicillin; AUG, augmentin; GEN, gentamycin; AMK, amikacin; TE, tetracycline; NAL, nalidixic acid; CIP, ciprofloxacin; SXT, trimethoprim- sulfamethoxazole; CR, chloramphenicol; MER, meropenem.